Na INR e phahameng e bolela ho tsoa mali kapa ho koala?


Mongoli: Mohlahlami   

Hangata INR e sebelisoa ho lekanya phello ea li-anticoagulants tsa molomo ho lefu la thromboembolic.INR e telele e bonoa ka li-anticoagulants tsa molomo, DIC, khaello ea vithamine K, hyperfibrinolysis joalo-joalo.INR e khutsufalitsoeng hangata e bonoa maemong a hypercoagulable le mathata a thrombotic.INR, eo hape e tsejoang e le International Normalized Ratio, ke e 'ngoe ea lintho tsa tlhahlobo ea tšebetso ea coagulation.INR e ipapisitse le sesebelisoa sa PT ho lekanya Index ea Sensitivity ea Machaba le ho bala sephetho ka liforomo tse amanang.Haeba INR e phahame haholo, ho na le kotsi ea ho tsoa mali ho sa laoleheng.INR e khona ho beha leihlo le ho sebelisa phello ea litlhare tsa anticoagulant ka nepo.Ka kakaretso, ho sebelisoa anticoagulant drug warfarin, 'me INR e hloka ho behoa leihlo ka linako tsohle.U lokela ho tseba hore haeba ho sebelisoa warfarin, INR e tlameha ho behoa leihlo khafetsa.Bakuli ba nang le venous thrombosis ba tlameha ho nka warfarin ka molomo, 'me boleng ba INR ka kakaretso bo lokela ho bolokoa ho 2.0-2.5.Bakeng sa bakuli ba atrial fibrillation, boleng ba inr ba warfarin ea molomo hangata bo bolokiloe lipakeng tsa 2.0-3.0.Litekanyetso tsa INR tse ka holimo ho 4.0 li ka baka ho tsoa mali ho sa laoleheng, ha litekanyetso tsa INR tse ka tlase ho 2.0 ha li fane ka anticoagulation e sebetsang.

Tlhahiso: u ntse u ea sepetlele se tloaelehileng ho ea hlahlojoa, 'me u mamele tokisetso ea ngaka ea setsebi.

Beijing Succeeder e ikhethang ho lihlahisoa tsa tlhahlobo ea thrombosis le hemostasis bakeng sa mmaraka oa lefats'e.

E le e 'ngoe ea lihlahisoa tse ka sehloohong tsa China Diagnostic market of Thrombosis and Hemostasis .SUCCEEDER e na le lihlopha tse nang le phihlelo tsa R&D,Production,Marketing Sales and Service Supplying coagulation analyzers and reagents,blood rheology analyzers ESR and HCT analyzers platelet aggregation analyzers with CE ISO1348 and 5 FDA Certification thathamisitsoe.